DOJ Declines Prosecution of Healthcare Company Under New Enforcement Policy, Indicts Former CEO
The Department of Justice (DOJ) has announced its first declination of a healthcare company under the new 2026 Corporate Enforcement and Voluntary Self-Disclosure Policy. The DOJ's National Fraud Enforcement Division decided not to prosecute Campus Eye Management Holdings, LLC and Campus Eye Management LLC, collectively known as Campus Eye. However, the company's founder and former CEO, E. Bruce DiDonato, has been indicted on charges of healthcare fraud and violations of the Anti-Kickback Statute. The DOJ credited Campus Eye's declination to its prompt self-disclosure, full cooperation, and aggressive remediation efforts. This decision marks a significant development in the DOJ's approach to corporate enforcement, emphasizing the importance of corporate cooperation in identifying and prosecuting culpable executives.